Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTD vs TD for Untreated Multiple Myeloma and Double Autologous Transplantation
NCT01134484Phase 3Unknown
- Start
- May 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM). Status: unknown.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01134484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134484.